Thimble Point

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch Thimble Point and buy or sell other stocks, options, and ETFs commission-free!

About THMA

Pear Therapeutics, Inc. is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics (PDT), which use software to treat diseases directly. The firm aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. It has a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA. 

CEO
Corey M. McCann, MD, PhD
CEOCorey M. McCann, MD, PhD
Employees
300
Employees300
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2020
Founded2020
Employees
300
Employees300

THMA Key Statistics

Market cap
1.29B
Market cap1.29B
Price-Earnings ratio
12.69
Price-Earnings ratio12.69
Dividend yield
Dividend yield
Average volume
382.28K
Average volume382.28K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$14.60
52 Week high$14.60
52 Week low
$1.34
52 Week low$1.34
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.